← Leaderboards
Joao Paulo De Aquino
Yale University
$2,201,525
Attributed
$2,201,525
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $646.2K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,201,525 · 3
By mechanism
K23$958,500 · 1
R01$883,050 · 1
R21$359,975 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Frederick Lewis Altice$47,021,698
- Jane R. Taylor$21,569,015
- David Fiellin$24,843,505
- Sandra Ann Springer$27,149,168
- Declan T. Barry$6,467,209
Others in their field
Other Emerging Leaders on “Oral”
- Yunda Huang · Fred Hutchinson Cancer Center$53,780,853
- Susan Abushakra · Alzheon, Inc.$50,765,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$40,061,627
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
- Gary Fanger · Rise Therapeutics, Llc$23,676,385
- James Dale Berry · Brigham And Women'S Hospital$15,344,018
Research focus
OralDosePain SensitivityParticipantPlacebosPharmaceutical PreparationsPainLaboratory StudySensoryResponseRandomizedCannabinoidsAnalgesicsIndexingAdverse EffectsPlacebo ControlAbuse LiabilityPersonsHourAddictionCannabidiolClinical TrialsEndogenous Cannabinoid SystemDsm-V
Grant awards (9)
Combination of THC and CBD as a Novel Treatment for Co-Occurring Opioid Addiction and Chronic Pain$454,523
R01 · FY2025 · DA · contact PI
Cannabidiol Pharmacotherapy for Comorbid Opioid Addiction and Chronic Pain$191,700
K23 · FY2025 · DA · contact PI
Combination of THC and CBD as a Novel Treatment for Co-Occurring Opioid Addiction and Chronic Pain$428,527
R01 · FY2024 · DA · contact PI
Cannabidiol Pharmacotherapy for Comorbid Opioid Addiction and Chronic Pain$191,700
K23 · FY2024 · DA · contact PI
Pharmacokinetics and Pharmacodynamics of Oral and Vaporized THC in Older Adults$196,350
R21 · FY2023 · DA · contact PI
Cannabidiol Pharmacotherapy for Comorbid Opioid Addiction and Chronic Pain$191,700
K23 · FY2023 · DA · contact PI
Cannabidiol Pharmacotherapy for Comorbid Opioid Addiction and Chronic Pain$191,700
K23 · FY2022 · DA · contact PI
Pharmacokinetics and Pharmacodynamics of Oral and Vaporized THC in Older Adults$163,625
R21 · FY2022 · DA · contact PI
Cannabidiol Pharmacotherapy for Comorbid Opioid Addiction and Chronic Pain$191,700
K23 · FY2021 · DA · contact PI